CymaBay Therapeutics (CBAY) Earnings
|
Expand Research on CBAY
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -37.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -5.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/9/24 | Q124 | N/A | -$0.32 | N/A | N/A | $57.14K | N/A | N/A | N/A | ||
| 3/14/24 | Q423 | N/A | -$0.31 | N/A | N/A | $377.78K | N/A | N/A | N/A | ||
| 2/28/24 | Q423 | -$0.35 | -$0.31 | -$0.04 | N/A | $377.78K | N/A |  | | Details | |
| 11/7/23 | Q323 | -$0.32 | -$0.29 | -$0.03 | N/A | $222.22K | N/A | | | Details | |
| 8/10/23 | Q223 | -$0.01 | -$0.20 | +$0.19 | $31M | $11.38M | N/A | | | Details | |
| 5/15/23 | Q123 | -$0.29 | -$0.09 | -$0.20 | N/A | $28.47M | N/A | | | Details | |
| 5/11/23 | Q123 | N/A | -$0.09 | N/A | N/A | $28.47M | N/A | N/A | N/A | ||
| 3/16/23 | Q422 | -$0.30 | -$0.30 | $0.00 | N/A | $5M | N/A | | | Details |
